What We're Reading: Page 228
Industry reads hand-picked by our editors
Nov 20, 2019
-
The Wall Street Journal
Generic-Drug Approvals Soar, But Patients Still Go Without
-
Associated Press
OxyContin maker thrives in China with abandoned US tactics
-
Ventura County Star
Thousand Oaks-based biotech company Amgen eliminating jobs
Nov 19, 2019
Nov 18, 2019
Nov 15, 2019
-
MIT Technology Review
One of CRISPR's inventors has called for controls on gene-editing technology
-
STAT
A drug maker courted controversy when it shut out a family-run rival. Now some patients say the medicine isn’t working
-
CNN
FDA issues warning to Dollar Tree about selling 'potentially unsafe drugs'
-
ProPublica
New EPA Rules Aim to Reduce Toxic Emissions. But Many "Cancer Alley" Chemical Plants Won’t Have to Change.
Nov 14, 2019
-
BioCentury
At Trump’s demand, IPI proposal changed to get ‘best deal’ on Part B drugs
-
The New York Times
To drive down insulin prices, W.H.O. will certify generic versions
-
Reuters
Rollout of Johnson & Johnson Ebola vaccine begins in Congo
-
Nature
Founding a global biotechnology summit — while pursuing a PhD
Previous
